-
Mashup Score: 2RISE Conference 2023 - 1 year(s) ago
RISE was developed to provide women across medical specialties with an opportunity to grow professionally: gaining access to trainings, insights and opportunities for their future success.
Source: Rise Conference 2023Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 16New research award added to $24 million grant to foster diversity in clinical trial research - 1 year(s) ago
DALLAS, Dec. 5, 2022 — The American Heart Association — the world’s leading voluntary organization dedicated to a world of longer, healthier lives — has announced an additional $4 million grant to add a sixth scientific research center and bring total …
Source: American Heart AssociationCategories: Cardiologists, Latest HeadlinesTweet-
New research award added to $24 million grant to foster diversity in clinical trial research | AHA —Major congrats to @ErinMichos, world leader in Women’s Health on this new AHA center grant! 👏👏👏 @hopkinsheart @CiccaroneCenter https://t.co/tHR2zv1Iqi
-
-
Mashup Score: 12 Cases of Elusive Left Ventricular Outflow Tract Gradient - 2 year(s) ago
Patients with hypertrophic cardiomyopathy (HCM) typically have septal hypertrophy and left ventricular outflow tract gradient, usually present at rest…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic - 2 year(s) ago
On December 22, 2021, the United States FDA approved inclisiran, an siRNA targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and statin therapy for low-density lipoprotein cholesterol (LDL-C) reduction in adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD).1 Inclisiran has demonstrated ∼50%…
Source: Journal of Clinical LipidologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity - 2 year(s) ago
Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity.
Source: GastroenterologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Eating within set times good for shift workers - 2 year(s) ago
Time-restricted eating reduced blood pressure and cholesterol in a study of US firefighters.
Source: BBC NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Feasibility of time-restricted eating and impacts on cardiometabolic health in 24-h shift workers: The Healthy Heroes randomized control trial - 2 year(s) ago
Manoogian et al. assessed time-restricted eating (TRE) as a potential lifestyle intervention to improve the health of 24-h shift workers. TRE was feasible and led to improvements in quality of life and cardiometabolic health, especially among participants with abnormal cardiometabolic measures at baseline.
Source: Cell MetabolismCategories: Cardiologists, Latest HeadlinesTweet-
Our study which is the first randomized controlled trial of time restricted eating (TRE) in shift workers (firefighters working 24-hour shifts) was published today in Cell Metabolism and featured on the cover. https://t.co/RY4uIj3a1o🧵 @ASPCardio @ACCinTouch @AHAScience @CMHC_CME https://t.co/evQfTdyKsV
-
-
Mashup Score: 0Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes - 2 year(s) ago
Native E. coli strains isolated from mouse stool are genetically engineered for long-term engraftment in the conventional mouse gut and enable long-term systemic effects on the host, such as improvements in insulin sensitivity in mouse models of type 2 diabetes.
Source: CellCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4What's New on the Lipid Management Landscape? - 2 year(s) ago
Drs Pam Taub and Steve Nissen discuss the current state of lipid management and what is on the horizon, thanks to the impact of highly anticipated new therapies to join the armamentarium.
Source: MedscapeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Postural Orthostatic Tachycardia Syndrome (POTS) is a complex, multisystem disorder characterized by orthostatic intolerance and tachycardia and may be triggered by viral infection. Recent reports indicate 2-14% of COVID-19 survivors develop POTS and 9-61% experience POTS-like symptoms, such as tachycardia, orthostatic intolerance, fatigue, and cognitive impairment within 6-8 months following a…
Source: Heart RhythmCategories: Cardiologists, Latest HeadlinesTweet
@ShrillaB @WomenAs1 @ShaziaTHussain1 @rallamee @aayshacader @MaasAngela @DrMarthaGulati @NicolaRyanI1 @BCSWIC @theharveys @BirkhoelzerS @BCIS_uk @BJCA_LTFT @rebeccaortega30 @Drroxmehran I am there! This is an amazing program organized by @Drroxmehran and @WomenAs1 ! https://t.co/DAfaJqE6AL Hope to see my friends there @EugeniaGianos @ErinMichos @ditchhaporia @FoodyMD @AnnMarieNavar @a_l_bailey @PamelaBMorris